Michel Surkyn

USPTO Granted Patents = 15 (Patent Applications = 8)

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 12 (Patent Applications = 12)

Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 41(Granted Patents)

Location History:

Turnhout, BE (2002 - 2012)
Kessel-lo, BE (2003 - 2012)
Beerse, BE (2013 - 2016)
Merksplas, BE (2014 - 2017)

Company Filing History:

11 out of 2,077

Janssen Pharmaceutica Nv

patents

4 out of 159

Janssen Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2002-2017

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9580433 - 4-amino-6-phenyl-5,6-dihydroimidazo[1,5-A]pyrazine derivatives as inhibitors of beta-secretase (BACE) (2017-02-28),

2. 9284303 - Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group (2016-03-15),

3. 9079886 - Substituted triazole derivatives as gamma secretase modulators (2015-07-14),

4. 8946426 - Substituted bicyclic heterocyclic compounds as gamma secretase modulators (2015-02-03),

5. 8946266 - Substituted triazole and imidazole derivatives as gamma secretase modulators (2015-02-03),

6. 8772504 - Substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators (2014-07-08),

7. 8524757 - Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group (2013-09-03),

8. 8318742 - Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives (2012-11-27),

9. 8193369 - Benzimidazole cannabinoid agonists (2012-06-05),

10. 8063070 - Bicyclic benzamides of 3-or 4-substituted 4-(aminomethyl)-piperidine derivatives (2011-11-22),

11. 7790750 - Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives (2010-09-07),

12. RE40793 - Bicyclic benzamides of 3-or 4-substituted 4-(aminomethyl)-piperidine derivatives (2009-06-22),

13. 6750349 - Gastrokinetic monocyclic benzamides of 3-or 4-substituted 4-(aminoethyl)-piperidine derivatives (2004-06-15),

14. 6635643 - Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives (2003-10-21),

15. 6452013 - Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives (2002-09-17),

Title: Innovations of Michel Surkyn - A Pioneer in Pharmaceutical Patents

Introduction

Michel Surkyn, an accomplished inventor based in Merksplas, Belgium, stands out in the realm of pharmaceutical innovations. With an impressive portfolio of 15 patents, Surkyn has made significant contributions, particularly in the fields of beta-secretase inhibitors and cannabinoid receptor agonists. His research is vital for developing treatments for several critical health issues, including Alzheimer's disease.

Latest Patents

Among his latest inventions is the patent for "4-amino-6-phenyl-5,6-dihydroimidazo[1,5-A]pyrazine derivatives as inhibitors of beta-secretase (BACE)." This invention focuses on novel compounds that serve as inhibitors of beta-secretase enzymes, including BACE1 and BACE2, which play a significant role in the pathology of Alzheimer's disease and related disorders. Furthermore, Surkyn has developed "Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group." This patent pertains to innovative compounds that have potential therapeutic effects on diseases influenced by cannabinoid receptors in humans.

Career Highlights

Michel Surkyn has garnered substantial experience working with leading pharmaceutical companies, notably Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc. His career is marked by his dedication to advancing drug development through innovative solutions and research.

Collaborations

Throughout his career, Surkyn has collaborated with notable peers, including Michel Anna Jozef De Cleyn and Henricus Jacobus Maria Gijsen. These collaborations have been instrumental in furthering research and development in pharmaceutical innovations.

Conclusion

In conclusion, Michel Surkyn’s contributions to the field of pharmaceutical science through his inventions and patents play a critical role in addressing some of today's most challenging health issues. His work continues to inspire innovation and collaboration in the pursuit of effective medical treatments.

This text is generated by artificial intelligence and may not be accurate.